Ophthalmology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Clin Exp Ophthalmol. 2021 Mar;49(2):203-211. doi: 10.1111/ceo.13899. Epub 2021 Jan 22.
Thyroid eye disease (TED) is a debilitating, vision threatening disease that dramatically alters patients' quality of life. Until recently, the management of TED is a long arduous course with supportive therapy, followed by an extensive surgical treatment plan to reverse the disease endpoints. Teprotumumab offers an early, safe therapeutic intervention to help reverse disease end points such as diplopia and proptosis and improve quality of life.
甲状腺眼病（TED）是一种使人虚弱、威胁视力的疾病，极大地改变了患者的生活质量。直到最近，TED 的治疗一直是一个漫长而艰巨的过程，包括支持性治疗，然后是广泛的手术治疗计划来逆转疾病终点。特普洛单抗提供了一种早期、安全的治疗干预措施，有助于逆转复视和眼球突出等疾病终点，并改善生活质量。
